NCT00902902 A Clinical Study of GP73 as a Hepatocellular Carcinoma (HCC) Tumor Mark Status UNKNOWN Phase N/A
NCT00877136 A Treatment of Unresectable Hepatocellular Carcinoma With TheraSphere® Status COMPLETED Phase N/A
NCT00877071 LC Drug Eluting Bead for Treatment of Liver Cancer Which Cannot be Surgically Removed Status COMPLETED Phase PHASE2
NCT00867750 SIR-Spheres® Microspheres Versus Transarterial Chemoembolisation in Patients With Unresectable Hepatocellular Carcinoma Status COMPLETED Phase PHASE2
NCT00862082 Randomized Phase 1/2 Open-Label Trial of PR104 and Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC) Status TERMINATED Phase PHASE1/PHASE2
NCT00858000 Analysis of Expression of Specific Markers in Hepatocellular Carcinoma Status COMPLETED Phase N/A
NCT00851968 A Trial of Complete Versus Selective HepaticVascular Clamping in Hepatectomy Status COMPLETED Phase NA
NCT00849264 Comprehensive Treatment for Different Types of Tumor Thrombi in the Portal Vein for Hepatocellular Carcinoma Patients Status COMPLETED Phase PHASE2
NCT00848952 Performance of Imaging for the Diagnosis of Small Hepatocellular Carcinoma (< 3 cm)on Cirrhosis Status UNKNOWN Phase NA
NCT00846131 Y-90 Alone or With Sorafenib for Pre-Transplant Hepatocellular Carcinoma Status COMPLETED Phase PHASE1
NCT00844883 Study of Sorafenib and Transarterial Chemoembolization (TACE) to Treat Hepatocellular Carcinoma Status COMPLETED Phase PHASE2
NCT00844688 Study of Sorafenib and Gemcitabine in Advanced Hepatocellular Carcinoma (HCC) Status UNKNOWN Phase PHASE2
NCT00844454 Multi-pronged Ethanol Ablation and Radiofrequency Ablation of Early-stage Hepatocellular Carcinoma Status COMPLETED Phase NA
NCT00842647 Diagnosis of Hepatic Tumors in Cirrhosis: Prospective Validation of the Noninvasive Diagnostic Criteria for Hepatocellular Carcinoma Status UNKNOWN Phase N/A
NCT00838968 The Efficiency of Postoperative Interferon-alpha Treatment in p48 Positive Patients With Hepatocellular Carcinoma Status WITHDRAWN Phase NA
NCT00834860 Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Hepatocellular Carcinoma Status UNKNOWN Phase PHASE4